There are couple of moments in every industry’s history that an insider breaks rank and produces information that are highly valuable and are not easily achievable. After being taunted for many days years, Martin Shkreli in a “Trump” style punches back at the pharmaceutical lobbyists who tried to pile on top of him and skape goat him for their own dark past. we have both uploaded the video for you in here and provide you the link to Shkreli’s YouTube channel. In case the big bad wolf of the left took hid channel down, we still can have this very valuable dirty laundry in here.
By: Martin Shkreli
He has also created a domain under this name: “pharmaskeletons.com”
Here is a part of that site:
Welcome to Pharma Skeletons, by Martin Shkreli.
1- Stephen Ubl,
Don’t you dare point your finger at me for the pharmaceutical industry’s troubles. It turns out we’ve all made some unpopular moves.
Abbott still raises the price of Humira, every year. This is despite Humira being the best selling drug on the planet.
Allergan pretends 10% price increases make sense in a no-inflation environment. Just assume no one can do math. A big price increase on a small product is worse than small increases on big products, right?
But everyone else is the bad actor, not us.
Don’t forget the inversion to avoid taxes, as well as their attempt to reverse merge with Pfizer to take them out of the U.S. tax system as well.
Remember that this is the company that does not do any R&D — they buy-in and call that “open science”. Open bullshit.
The company hasn’t had a science-oriented CEO in decades. Their R&D productivity is pathetic.
We sell… cough syrup? We got a patent on the cough syrup for pseudobulbar affect. Somehow it got FDA approved.
It’s not a big selling drug or anything, but we need lobbying.
We raise prices on drugs by 100%+ but no one notices.
Tecfidera was a cheap drug available overseas.
New drug costs $750,000 its first year and ~$300,000 every year thereafter. Daraprim is $25,000 one time. Get mad!
Biogen doesn’t fool anyone into thinking they’re “innovative”.
Kuvan doesn’t cost much in Europe.
It sure is easy to pretend you’re a model citizen when your company went through a pretty ugly period fifteen years ago.
You can find the rest of the big pharma’s dark secrets in his new site pharmaskeletons.com